1. Home
  2. CORT vs RRC Comparison

CORT vs RRC Comparison

Compare CORT & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • RRC
  • Stock Information
  • Founded
  • CORT 1998
  • RRC 1976
  • Country
  • CORT United States
  • RRC United States
  • Employees
  • CORT N/A
  • RRC N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • RRC Oil & Gas Production
  • Sector
  • CORT Health Care
  • RRC Energy
  • Exchange
  • CORT Nasdaq
  • RRC Nasdaq
  • Market Cap
  • CORT 7.6B
  • RRC 8.4B
  • IPO Year
  • CORT N/A
  • RRC N/A
  • Fundamental
  • Price
  • CORT $69.53
  • RRC $35.10
  • Analyst Decision
  • CORT Strong Buy
  • RRC Hold
  • Analyst Count
  • CORT 4
  • RRC 18
  • Target Price
  • CORT $139.00
  • RRC $43.06
  • AVG Volume (30 Days)
  • CORT 644.6K
  • RRC 2.7M
  • Earning Date
  • CORT 10-29-2025
  • RRC 10-21-2025
  • Dividend Yield
  • CORT N/A
  • RRC 1.02%
  • EPS Growth
  • CORT N/A
  • RRC 0.32
  • EPS
  • CORT 1.11
  • RRC 1.98
  • Revenue
  • CORT $716,080,000.00
  • RRC $2,799,229,500.00
  • Revenue This Year
  • CORT $30.62
  • RRC $30.36
  • Revenue Next Year
  • CORT $37.68
  • RRC $14.88
  • P/E Ratio
  • CORT $62.97
  • RRC $17.76
  • Revenue Growth
  • CORT 25.71
  • RRC 19.93
  • 52 Week Low
  • CORT $37.82
  • RRC $28.99
  • 52 Week High
  • CORT $117.33
  • RRC $43.50
  • Technical
  • Relative Strength Index (RSI)
  • CORT 45.26
  • RRC 53.60
  • Support Level
  • CORT $67.32
  • RRC $33.94
  • Resistance Level
  • CORT $74.79
  • RRC $35.76
  • Average True Range (ATR)
  • CORT 2.36
  • RRC 0.88
  • MACD
  • CORT 0.14
  • RRC 0.24
  • Stochastic Oscillator
  • CORT 29.58
  • RRC 75.56

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About RRC Range Resources Corporation

Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.

Share on Social Networks: